Skip to content
MNTN

MNTN Inc.

MNTN Inc. Q1 FY2026 earnings call

May 5, 2026 · fiscal period ended 2026-03

EPS · actual vs est

$0.11 / $0.12Miss -8.3%

Revenue · actual vs est

$73.7M / $72.6MBeat +1.4%
Ask about this call

Summary

Generated 2026-05-05

Management highlights

Product Performance - Pain management: 28% y-o-y growth, CrowdStrike Max Pro driving ~70% of sales, Cryo XD Pro for amputation starting to gain traction. - Cardiac ablation franchises: Worldwide open ablation revenue grew 15%, led by Encompass clamp; minimally invasive ablation faced headwinds. - Appendage management: 16% worldwide growth; open left atrial appendage management benefited from AtriClip Flex Mini in US (40% of open appendage management revenue); AtriClip Pro Mini building adoption in US; CE Mark for Flex Mini and Pro Mini in Europe expected to launch later this year. ### Clinical Trials - BOX NOAF clinical trial: Enrolled ~300 patients in 960-patient trial, expects complete enrollment end of 2026, nearly one year ahead of plan; driven by high surgeon engagement due to impact of postoperative AFib on patients. ### Financials - Worldwide revenue $140 million in Q1 2026, up 14% y-o-y; adjusted EBITDA $17 million, nearly double Q1 last year.

View in transcript ↓

Segment performance

Worldwide revenue was $140 million in Q1 2026, up 14% y-o-y. Pain management grew 28% y-o-y, with CrowdStrike Max Pro driving ~70% of sales; Cryo XD Pro for amputation starting to gain traction. Worldwide open ablation revenue grew 15%, led by Encompass clamp. Minimally invasive ablation faced headwinds. Appendage management grew 16% worldwide; open left atrial appendage management benefited from AtriClip Flex Mini in US (40% of open appendage management revenue); AtriClip Pro Mini building adoption in US. International markets growing adoption of legacy devices, with CE Mark for Flex Mini and Pro Mini in Europe expected to launch later this year.

View in transcript ↓

Guidance

Forward-looking - Expect adjusted EBITDA to be between $96 million and $101 million. ### Growth Expectations - Q2 guide $81 million to $83 million, 20% y-o-y growth; fiscal year guide $347 million to $357 million, 24% growth at midpoint. ### Onboarding - Mid-market has been consistently growing; small business onboarding is tuned to be sustainable, responsible, and profitable, with dedicated teams working on it.

View in transcript ↓

Q&A highlights

Q: Shyam Patil asked about significant hires and their envisioning.

A: Mark Douglas said the market is moving from early adopter to mainstream, added individuals like Garland Hill and Peter Blacker who bring valuable experience, networks, etc.

Q: Ronald Josey asked about streaming partners and QuickFrame AI 3.0.

A: Mark Douglas said they have relationships with virtually every streaming network in America, Peter's experience helps ensure access to all content; QuickFrame AI version three is fully ready, stats on sales cycles and conversion rates are being tracked.

Q: Andrew Boone asked about guidance and onboarding pacing.

A: Patrick Pohlen said full-year guide implies back half acceleration, they see strong PTV business growth; Mark Douglas talked about mid-market vs small business onboarding, dedicated teams tuning small business onboarding.

Q: Robert Coolbrith asked about QuickFrame AI beta benefits and gross margin.

A: Mark Douglas said QuickFrame AI version three is ready due to positive customer metrics, technology investment; Patrick Pohlen said gross margin was better due to revenue growth, spinning out Maximum Effort and switching hosting providers.

Q: Matt Weber asked about SMB advertiser base and media planning tool.

A: Mark Douglas said SMB advertiser base not greatly affected by macro, media planning tool coming soon with positive reviews.

Q: Andrew Merrick asked about Pinterest announcements and World Cup boost.

A: Mark Douglas said Pinterest's interest in TV Scientific not competitive in sales cycles; World Cup inventory available, but spend driven by ROAS.

Q: Robert Sanderson asked about go-to-market evolution and direct sales expansion.

A: Mark Douglas said working with performance agencies, direct sales expansion is ongoing with no concerns; Patrick Pohlen said model has natural leverage so margin impact not expected.

Q: Laura Martin asked about orchestration and competitive advantage.

A: Mark Douglas said orchestration used in creative with proprietary tech; competitive advantage is highest performance in CTV, not going omnichannel yet

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS$0.11$0.12-8.3%
Revenue$73.7M$72.6M+1.4%

Transcript

May 5, 2026

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.